| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +100.00% | +1.99% | -2.29% | +4.28% | +4.86% | — |
| 14d | 4 | +100.00% | +3.71% | -1.14% | +4.84% | +4.94% | — |
| 30d | 4 | +100.00% | +8.36% | +0.95% | +7.40% | +7.19% | — |
| 60d | 4 | +50.00% | +22.35% | +0.30% | +22.05% | +15.16% | — |
| 90d | 4 | +50.00% | +86.19% | +2.49% | +83.70% | +83.96% | — |
| 180d | 4 | +100.00% | +49.52% | +8.87% | +40.65% | +41.98% | — |
| 1y | 4 | +50.00% | +1083.87% | +17.63% | +1066.24% | +1065.27% | — |
| 2y | 4(2 pending) | +100.00% | +1249.75% | +45.24% | +1204.51% | +1204.51% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,000,000 | — | — | 1,000,000 | Jan 23, 2026 | Jan 23, 2026 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | SALEGRANT Gift | 739,885 | — | — | 255,000 | Dec 10, 2025 | Dec 11, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Gift | 739,885 | — | — | 739,885 | Dec 10, 2025 | Dec 11, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,944 | $1.20 | $181.1K | 994,885 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,944 | $0.13 | $18.9K | 150,944 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,200,000 | — | — | 1,200,000 | Jan 28, 2025 | Feb 11, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CEO AND CHIEF MEDICAL OFFICER | 77,000 | $0.70 | $53.9K | 843,941 | Aug 30, 2024 | Sep 3, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CEO AND CHIEF MEDICAL OFFICER | 77,500 | $0.69 | $53.5K | 766,941 | Aug 29, 2024 | Sep 3, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,500,000 | — | — | 1,500,000 | Feb 1, 2024 | Feb 1, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 90,531 | $0.55 | $49.8K | 539,442 | Jan 16, 2024 | Jan 17, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 149,999 | $0.94 | $141.0K | 689,441 | Jan 16, 2024 | Jan 17, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | SALE CHIEF EXECUTIVE OFFICER | 149,999 | — | — | 450,001 | Jan 16, 2024 | Jan 17, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | SALE CHIEF EXECUTIVE OFFICER | 90,531 | — | — | 115,860 | Jan 16, 2024 | Jan 17, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 88,000 | $1.26 | $110.9K | 448,911 | Aug 10, 2023 | Aug 11, 2023 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 80,000 | $1.24 | $99.2K | 360,911 | Aug 8, 2023 | Aug 9, 2023 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 600,000 | — | — | 600,000 | Feb 1, 2023 | Feb 2, 2023 ↗ | View → |